Search

Sleep health is a good indicator to a person’s overall health status and general well-being. Proper sleep is one of the most important factors to healthy immunity. Protecting and restoring sleep quality are vital to well-being. Problems such as insomnia, obstructive sleep apnea, fatigue, and hypersomnia can all affect the quality of a person’s sleep. There are over 35 million people living with HIV/AIDS infection in the world. These people suffer from many of the same sleep problems and often have more frequent or more severe symptoms. It is not clear if this is from the disease, the medications, or some other factors. HIV-positive persons need good sleep quality to maintain their immune system and help keep the disease from progressing. Treatments for sleep disorders in HIV need to be considered carefully. Interventions should start with the least invasive progress to more invasive therapies and be monitored carefully.

Patients living with human immunodeficiency virus/acquired immunodeficiency syndrome (PLWHA) are at increased risk of cardiovascular disease because of advances in human immunodeficiency virus/acquired immunodeficiency syndrome treatment and increased life expectancy. Cardiovascular health promotion in PLWHA includes strategies for risk factor reduction, disease prevention, early detection, and treatment of cardiovascular disease.

This study describes physical activity level in outpatients with schizophrenia spectrum disorders (SSD) using extended-wear pedometers. Demographic data, body fat and body mass index (BMI) measures were obtained from 24 outpatients. Participants were provided extended-wear pedometers and instructed to wear them during waking hours for 1 week. More than 79% of subjects met Centres for Disease Control (CDC) obesity criteria. Participants wore pedometers, on average, 6 days during the week. Men walked more steps, walked longer distances, and burned more calories each day; differences were statistically significant for steps and distance on days 3 (t = 2.12, P = 0.045) and 5 (t = 2.19, P = 0.04). Higher percent body fat and BMI were significantly associated with fewer steps walked on most days. Extended-wear pedometers are an easy-to-use, cost-effective way to document physical activity and evaluate efforts to help this vulnerable group achieve activity-related health improvements.

This study describes physical activity level in outpatients with schizophrenia spectrum disorders (SSD) using extended-wear pedometers. Demographic data, body fat and body mass index (BMI) measures were obtained from 24 outpatients. Participants were provided extended-wear pedometers and instructed to wear them during waking hours for 1 week. More than 79% of subjects met Centres for Disease Control (CDC) obesity criteria. Participants wore pedometers, on average, 6 days during the week. Men walked more steps, walked longer distances, and burned more calories each day; differences were statistically significant for steps and distance on days 3 (t = 2.12, P = 0.045) and 5 (t = 2.19, P = 0.04). Higher percent body fat and BMI were significantly associated with fewer steps walked on most days. Extended-wear pedometers are an easy-to-use, cost-effective way to document physical activity and evaluate efforts to help this vulnerable group achieve activity-related health improvements.

Identification of procedures to document physical activity is critical to developing interventions to improve physical health. The purpose of this pilot study was to describe the feasibility and acceptability of pedometers to document physical activity in patients with schizophrenia spectrum disorders (SSDs). Twenty-four outpatients were provided with extended-wear pedometers and instructed to wear them daily for 1 week without altering their usual activities. All participants completed the 1-week data collection period. Twenty-one (87.5%) participants wore their pedometer at least 6 of the 7 days. Difficulties with the pedometers were few and minor. These preliminary findings indicate that a majority of individuals with SSDs are willing to wear pedometers for activity monitoring and can do so with few problems. Possible barriers to the use of extended-wear pedometers in this group include cognitive and memory deficits. Future investigations should test concurrent validity by examining the correlations between pedometer data and self-reported activity level.